{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:09Z","timestamp":1786118829852,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hypercalcemia is an uncommon but clinically significant complication of pediatric malignancies that often presents with symptoms. However, in this case series, we report 4 children with nonspecific symptoms of hypercalcemia detected incidentally on routine biochemical evaluation at the time of leukemia diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Presentation:<\/jats:title>\n                    <jats:p>Patients, 5 to 9 years of age, had underlying malignancies, including Hodgkin lymphoma (stage IIA), pre-B-cell acute lymphoblastic leukemia, and acute promyelocytic leukemia. All the patients presented with severe hypercalcemia, necessitating prompt intervention. Treatment consisted of hyperhydration, loop diuretics, bisphosphonates, and calcitonin, along with the management of the underlying malignancy. Successful resolution of hypercalcemia was achieved in all cases, with no future recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This case series highlights the importance of the routine biochemical screening for newly diagnosed pediatric malignancies, particularly for nonspecific symptoms of hypercalcemia, which may otherwise go unrecognized. Although hypercalcemia in hematological malignancies is well-documented, our findings stress the silent presentation and reinforce the clinical need for early identification to avoid metabolic complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003079","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:02:20Z","timestamp":1751385740000},"page":"e254-e259","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Hypercalcemia of Malignancy in Pediatric Population"],"prefix":"10.1097","volume":"47","author":[{"given":"Alpas","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9575-0805","authenticated-orcid":false,"given":"Neha","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4440-5339","authenticated-orcid":false,"given":"Amitabh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4707-6374","authenticated-orcid":false,"given":"Prashant","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashmat","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suruchi","family":"Viz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2499-7779","authenticated-orcid":false,"given":"Nidhi","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0024-8773","authenticated-orcid":false,"given":"Sumit","family":"Mehndiratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MOP.0b013e32833b7c23","article-title":"Hypercalcemia in children and adolescents","volume":"22","author":"Lietman","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"R2-20260422","first-page":"3365","article-title":"Hypercalcemia in pediatric patients with malignancy: updated review and practical approach","volume":"36","author":"Goldstein","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N Engl J Med"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/1097-0142(19930701)72:1<256::AID-CNCR2820720145>3.0.CO;2-D","article-title":"Hypercalcemia complicating childhood malignancies","volume":"72","author":"McKay","year":"1993","journal-title":"Cancer"},{"key":"R6-20260422","first-page":"377","article-title":"Hypercalcemia and cancer: differential diagnosis and treatment","volume":"68","author":"Zagzag","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2147\/CLEP.S137616","article-title":"Prevalence of hypercalcemia of malignancy among pediatric cancer patients in the UK clinical practice research datalink database","volume":"9","author":"Jick","year":"2017","journal-title":"Clin Epidemiol"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"402","DOI":"10.12659\/AJCR.914303","article-title":"Acute lymphoblastic leukemia with malignant hypercalcemia: a case report","volume":"20","author":"Bota","year":"2019","journal-title":"Am J Case Rep"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000380998","article-title":"Approach to the child with hypercalcaemia","volume":"28","author":"Davies","year":"2015","journal-title":"Endocr Dev"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00467-020-04603-6","article-title":"Hypercalcemia, hyperuricemia, and kidney dysfunction in a 35-month-old boy: answers","volume":"36","author":"Lin","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"R11-20260422","first-page":"51","article-title":"Hipercalcemia como urgencia m\u00e9dica. Rev Esp Enfermedades Metab Oseas","volume":"18","author":"Nuevo-Gonz\u00e1lez","year":"2009"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.ajkd.2013.06.025","article-title":"Approach to diagnosis and treatment of hypercalcemia in a patient with malig nancy","volume":"63","author":"Reagan","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.2215\/CJN.02470312","article-title":"Onco-nephrology: the patho physiology and treatment of malignancy-associated hyper calcemia","volume":"7","author":"Rosner","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"99","DOI":"10.6065\/apem.2016.21.2.99","article-title":"Successful treatment of hypercalcemia with zoledronic acid in a 15-year-old boy with acute lymphoblastic leukemia","volume":"21","author":"Park","year":"2016","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"R15-20260422","first-page":"e12","article-title":"Extreme hypercalcemia of malignancy in a pediatric patient: therapeutic considerations","volume":"1","author":"Fisher","year":"2015","journal-title":"AACE Clin Case Rep"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2022.18331","article-title":"Hypercalcemia: a review","volume":"328","author":"Walker","year":"2022","journal-title":"JAMA"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.356","article-title":"Bisphosphonate nephrotoxicity","volume":"74","author":"Perazella","year":"2008","journal-title":"Kidney Int"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.clgc.2014.11.008","article-title":"Severe hypocalcemia associ ated with denosumab in metastatic castration-resistant prostate cancer: risk factors and precautions for treating physicians","volume":"13","author":"Autio","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1517\/17425255.2011.562196","article-title":"Clinical utilization of cinacalcet in hypercalcemic conditions","volume":"7","author":"Messa","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12 suppl","key":"R20-20260422","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/1097-0142(20000615)88:12+<2909::AID-CNCR5>3.0.CO;2-7","article-title":"Parathyroid hormone-related protein as a potential target of therapy for cancer-associated morbidity","volume":"88","author":"Ogata","year":"2000","journal-title":"Cancer"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"402","DOI":"10.5935\/0103-507X.20150067","article-title":"Severe hypercalcemia as a form of acute lymphoblastic leukemia presentation in children","volume":"27","author":"Martins","year":"2015","journal-title":"Rev Bras Ter Intensiva"},{"key":"R22-20260422","first-page":"e28535","article-title":"Hypercalcemia in pediatric acute leukemia: characteristics, prognosis, and clinical outcomes","volume":"67","author":"Hayashi","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R23-20260422","first-page":"236","article-title":"Bisphosphonate therapy in pediatric patients with hypercalcemia of malignancy","volume":"24","author":"Stark","year":"2019","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/07357907.2015.1047506","article-title":"Quality and outcomes of treatment of hypercalcemia of malignancy","volume":"33","author":"Wright","year":"2015","journal-title":"Cancer Invest"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:53:29Z","timestamp":1786035209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003079"}},"subtitle":["Clinical Challenges Explored Through Cases\u2014A Case Series"],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003079","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"2024-10-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}